Adjuvant Chemotherapy Combined With Huaier Granule for Treating High-risk Stage II, Stage III Colorectal Cancer
A randomized, paralleled control clinical study investigating Huaier Granule for prevention of recurrence and metastasis of colorectal cancer after radical surgery, to evaluate the efficacy and safety.
Colorectal Cancer
DRUG: Huaier Granule|DRUG: Oxaliplatin|DRUG: Calcium folinate|DRUG: 5-fluorouracil
Disease-free survival (DFS), DFS was defined as the date of definitive surgery until the date of recurrence, metastasis, appearance of a second primary tumor, or death from any cause, whichever occurs first., 1 year
Overall survival (OS), OS was defined as the date of definitive surgery until the date of death or the last follow-up., 5 years|Relapse-free survival (RFS), RFS was defined as the date of definitive surgery until the date of recurrence or death from any cause., 5 years|Metastasis-free survival (MFS), MFS was defined as the date of definitive surgery until the date of metastasis or death from any cause., 5 years
The effects of Huaier Granule on adverse events of adjuvant chemotherapy., The adverse events were evaluated every 2 weeks; Eastern Cooperative Oncology Group(ECOG) scores, imaging assessment and related biochemical indicators., 6 months
A randomized, paralleled control clinical study investigating Huaier Granule for prevention of recurrence and metastasis of colorectal cancer after radical surgery, to evaluate the efficacy and safety.